OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

HTML

Year: 2003
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2003.06.122
Authors: Giorgio V. Scagliotti, Dong-M. Shin, Hedy L. Kindler, Michael J. Vasconcelles, Uwe Keppler, Christian Manegold, Howard Burris, Ulrich Gatzemeier, Johannes Blatter, James T. Symanowski, James J. Rusthoven
Institutions: Eli Lilly (United States), University of Pittsburgh, University of Chicago, Sarah Cannon, Eli Lilly (Germany), Dana-Farber Cancer Institute, University of Turin
Language: English

Topic: Occupational and environmental lung diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: malignant pleural mesothelioma, pemetrexed, folic acid, vitamin B12, vitamin supplementation, first-line chemotherapy, single-agent chemotherapy, overall survival, neutropenia, leukopenia, treatment toxicity, response rate
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2127235139
FWCI: 21.85
Cites: 29
Cited by: 266
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms